KMDS
E-submission
Search
- Page Path
- HOME > Search
Letter to the editor
- Parkinson’s Kinetigraph in the Selection of Levodopa-Carbidopa Intestinal Gel for Motor Fluctuations Refractory to Deep Brain Stimulation
- Yassine Noui, Monty Adam Silverdale, Julian Evans, Lucy Partington-Smith, Christopher Kobylecki
- J Mov Disord. 2021;14(3):239-241. Published online March 15, 2021
- DOI: https://doi.org/10.14802/jmd.20090
- 4,356 View
- 78 Download
- 2 Web of Science
- 2 Crossref
-
PDF
Supplementary Material -
Citations
Citations to this article as recorded by
- Predicting Motor Outcome and Quality of Life After Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The Role of Standard Screening Measures and Wearable-Data
Victor J. Geraedts, Jeroen P.P. van Vugt, Johan Marinus, Roy Kuiper, Huub A.M. Middelkoop, Rodi Zutt, Niels A. van der Gaag, Carel F.E. Hoffmann, Lucille D.A. Dorresteijn, Jacobus J. van Hilten, Maria Fiorella Contarino
Journal of Parkinson's Disease.2023; 13(4): 575. CrossRef - Novel therapeutic interventions for combating Parkinson’s disease and prospects of Nose-to-Brain drug delivery
Javed Ahmad, Nafis Haider, Mohammad Ahmed Khan, Shadab Md, Nabil A. Alhakamy, Mohammed M. Ghoneim, Sultan Alshehri, Syed Sarim Imam, Mohammad Zaki Ahmad, Awanish Mishra
Biochemical Pharmacology.2022; 195: 114849. CrossRef
- Predicting Motor Outcome and Quality of Life After Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The Role of Standard Screening Measures and Wearable-Data
First
Prev
